Journal Mobile Options
Table of Contents
Vol. 218, No. 1, 2009
Issue release date: December 2008
Dermatology 2009;218:44–47
(DOI:10.1159/000173695)

Botulinum Toxin Type A – Treatment of a Patient with Multiple Cutaneous Piloleiomyomas

Sifaki M.K. · Krueger-Krasagakis S. · Koutsopoulos A. · Evangelou G.I. · Tosca A.D.
Departments of aDermatology and bPathology, Faculty of Medicine, University of Crete, Heraklion, Greece

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Treatment of multiple cutaneous piloleiomyomas which are rare, frequently painful, benign tumors originating from the arrector pilorum muscle of hair follicles is difficult. Objective: To determine the efficiency of botulinum toxin type A (BT-A) treatment for pain relief of cutaneous piloleiomyomas. Methods: A patient with multiple painful piloleiomyomas was treated with local injections of 200 units of BT-A. Results: There was a rapid and sustained decrease in pain. Treatment was repeated every 3 months for 2 years with the same efficacy. Conclusion: BT-A may be a promising new treatment option for multiple painful cutaneous piloleiomyomas.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Calonje E, MacKie RM: Soft-tissue tumours and tumour-like conditions; in Burns T, Breathnach S, Cox N, Griffith C (eds): Rook’s Textbook of Dermatology, ed 7. Oxford, Blackwell Science, 2004, vol 3, pp 53.40–53.42.
  2. Montgomery H, Winkelman RK: Smooth muscle tumors of the skin. Arch Dermatol 1959;79:32–41.
  3. Raj S, Calonje E, Kraus M, Kavanagh G, Newman PL, Fletcher CD: Cutaneous pilar leiomyoma: clinicopathologic analysis of 53 lesions in 45 patients. Am J Dermatopathol 1997;19:2–9.
  4. Garcia Muret MP, Pujol RM, Alomar A, Calaf J, de Moragas JM: Familial leiomyomatosis cutis et uteri (Reed’s syndrome). Arch Dermatol Res 1988;280(suppl):S29–S32.

    External Resources

  5. Martinez-Mir A, Gordon D, Horev L, Klapholz L, Ott J, Christiano AM, Zlotogorski A: Multiple cutaneous and uterine leiomyomas: refinement of the genetic locus for multiple cutaneous and uterine leiomyomas on chromosome 1q 42.3–43. J Invest Dermatol 2002;118:876–880.
  6. Archer CB, Greaves MW: Assessment of treatment for painful cutaneous leiomyomas. J Am Acad Dermatol 1987;17:141–142.
  7. Alam M, Rabinowitz AD, Engler DE: Gabapentin treatment of multiple piloleiomyoma-related pain. J Am Acad Dermatol 2002;46:S27–S29.
  8. Mann PR: Leiomyoma cutis: an electron microscope study. Br J Dermatol 1970;82:463–469.
  9. Cherington M: Clinical spectrum of botulism. Muscle Nerve 1998;21:701–710.
  10. Münchau A, Bhatia KP: Uses of botulinum toxin injection in medicine today. BMJ 2000;320:161–165.
  11. Ji J, Lau H, Sheu L, Diamant NE, Gaisano HY: Distinct regional expression of SNARE proteins in the feline oesophagus. Neurogastroenterol Motil 2002;14:383–394.
  12. Vaidyanathan VV, Yoshino K, Jahnz M, Dorries C, Bade S, Nauenburg S, Niemann H, Binz T: Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage. J Neurochem 1999;72:327–337.
  13. Arezzo JC: Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain 2002;18(suppl):S125–S132.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00